🏢 Eligara Demo: Viewing sites.eligara.ai (Patient Portal)
Switch to recruit.eligara.ai (Port 8002) →
Two-Sided Communication Portal

Study Coordinator Inquiries

Clinical trial recruiters and research coordinators from recruit.eligara.ai screen de-identified cases and send invitations directly to your portal.

👁️ View Recruiter's Tracker on port 8002 →
🛡️
How Privacy Works: Study coordinators review de-identified clinical summaries and never see your name, contact information, or medical records. Contact details are only unlocked if you affirmatively choose "I'm Interested in Connecting".
SC
Recruiter Inquiry Case: Alice Johnson Telescope • Yesterday at 2:30 PM

Dr. Sarah Chen, MD • Dana-Farber Cancer Institute

Lead Clinical Research Coordinator, Center for Thoracic Oncology
NCT05481234
Clinical Trial Protocol

Phase 2 Study of Targeted Combination Therapy in EGFR-Mutated Advanced NSCLC

📍 Study Location: Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02115
Invitation Message:

Dear Patient, Our clinical research team at Dana-Farber Cancer Institute has reviewed your de-identified case summary on Eligara and identified your clinical profile as a potential match for our enrolling targeted therapy trial (NCT05481234: Osimertinib + Combination in EGFR-Mutant NSCLC). If you are interested in exploring whether this trial could be an appropriate next step in your treatment plan, please tap 'I am Interested in Connecting' below. We would be delighted to provide comprehensive trial documentation and discuss with you or your treating oncologist. Best regards, Dr. Sarah Chen, MD Lead Study Coordinator, Dana-Farber Cancer Institute

Clicking "Interested" securely shares your contact preference with Dana-Farber.
SC
Recruiter Inquiry Case: Robert Davis Compass • Sept 6, 2026

Dr. Sarah Chen, MD • Dana-Farber Cancer Institute

Lead Clinical Research Coordinator, Center for Thoracic Oncology
NCT05481234
Clinical Trial Protocol

Phase 2 Study of Targeted Combination Therapy in EGFR-Mutated Advanced NSCLC

📍 Study Location: Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA 02115
Invitation Message:

Inviting candidate for screening protocol participation.

✓ Connected • Contact Coordinates Unlocked

You indicated interest on Sept 7, 2026 9:20 AM. Dr. Sarah Chen's study team at Dana-Farber Cancer Institute has been notified and granted permission to reach out to you via your email (eleanor.vance@gmail.com).